Table: begin end state 1 23 signal peptide 24 30 non-cytoplasmic 31 51 transmembrane 52 58 cytoplasmic 59 79 transmembrane 80 100 non-cytoplasmic 101 132 transmembrane 133 143 cytoplasmic 144 168 transmembrane 169 195 non-cytoplasmic 196 221 transmembrane 222 241 cytoplasmic 242 262 transmembrane 263 267 non-cytoplasmic 268 284 transmembrane 285 297 cytoplasmic 298 321 transmembrane 322 336 non-cytoplasmic 337 359 transmembrane 360 363 cytoplasmic 364 410 transmembrane 411 423 cytoplasmic 424 450 transmembrane 451 458 non-cytoplasmic
Input: >WP_090447305.1 NCBI__GCF_900100495.1:WP_090447305.1 MVELMAILLFVSICLALMAGFPVAFTLGGVSLLFAGIGMLTGTFDAGYLSALPNRLFGIM NNQTMLAVPLFVFMGVMLEKSRVAEDLLESMSRLFGTLRGGLAISVCVVGALLAASTGIV GATVVTMGLLALPTMLRRGYDPAIATGTLAATGTLGQIIPPSIVLVLLGDVMSSAYQQAQ LKMGIFSPKTVSVGDLFVGAFLPGMALVGLYILYIIAIAVLQPKKLPALPQEELGPIEWG KLFAALLPPLILIAAVLGSILAGYATPTEAAALGALGAMLLALGKRKLNFGQLREVAYGT TEISAMVFMILIGASLFSLVFRGFGGEVLIEDVFAQLPGGVLGAFFVVMLVIFLLGFILD FIEITFVVVPIVGPVLLAMGLDPIWLGVMIALNLQTSFLTPPFGFALFYLRGVTPPSVPT STIYRGVLPFILLQILMLVIAYIFPGLITWLPEQVYGK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server